"CD4-CD8 Ratio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.
| Descriptor ID |
D016516
|
| MeSH Number(s) |
E01.370.225.500.195.107.595.500.150.160 E01.370.225.625.107.595.500.150.160 E05.200.500.195.107.595.500.150.160 E05.200.625.107.595.500.150.160 E05.242.195.107.595.500.150.160 G04.140.107.595.500.150.160 G09.188.105.595.500.150.160 G12.248
|
| Concept/Terms |
CD4-CD8 Ratio- CD4-CD8 Ratio
- CD4 CD8 Ratio
- CD4-CD8 Ratios
- T4-T8 Ratio
- T4 T8 Ratio
- T4-T8 Ratios
|
Below are MeSH descriptors whose meaning is more general than "CD4-CD8 Ratio".
Below are MeSH descriptors whose meaning is more specific than "CD4-CD8 Ratio".
This graph shows the total number of publications written about "CD4-CD8 Ratio" by people in this website by year, and whether "CD4-CD8 Ratio" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD4-CD8 Ratio" by people in Profiles.
-
Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell. Immunol Lett. 2007 Jan 15; 108(1):78-87.
-
Innate immunity involved in the pathogenesis of nonalcoholic steatohepatitis. Liver Transpl. 2006 Oct; 12(10):1553-4.
-
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant. 2006 Jan; 12(1 Suppl 2):22-30.
-
Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J Immunol. 2005 Jan 15; 174(2):800-7.
-
Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells. Bone Marrow Transplant. 2004 Mar; 33(5):491-7.
-
T cell development in mice expressing CD1d directed by a classical MHC class II promoter. J Immunol. 2003 Oct 15; 171(8):4096-104.
-
Increased CD4+ T cells during acute attack of Ménière's disease. Acta Otolaryngol. 2002 Dec; 122(8):857-60.
-
[Lymphocyte subpopulations of peripheral blood in children with Schönlein-Henoch purpura and IgA nephropathy]. Pol Merkur Lekarski. 2001 Apr; 10(58):244-6.
-
Human fetal retinal pigment epithelium suppresses the activation of CD4(+) and CD8(+) T-cells. Graefes Arch Clin Exp Ophthalmol. 1999 Nov; 237(11):934-9.
-
Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report. J Clin Exp Neuropsychol. 1999 Oct; 21(5):730-5.